BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1049 related articles for article (PubMed ID: 17140280)

  • 1. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral zolmitriptan in the short-term prevention of menstrual migraine: a randomized, placebo-controlled study.
    Tuchman MM; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2008; 22(10):877-86. PubMed ID: 18788838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
    CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study.
    Loder E; Silberstein SD; Abu-Shakra S; Mueller L; Smith T
    Headache; 2004 Feb; 44(2):120-30. PubMed ID: 14756849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
    Rothner AD; Wasiewski W; Winner P; Lewis D; Stankowski J
    Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study.
    Geraud G; Compagnon A; Rossi A;
    Eur Neurol; 2002; 47(2):88-98. PubMed ID: 11844897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet.
    Spierings EL; Rapoport AM; Dodick DW; Charlesworth B
    CNS Drugs; 2004; 18(15):1133-41. PubMed ID: 15581383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.
    Loder E; Freitag FG; Adelman J; Pearlmand S; Abu-Shakra S
    Curr Med Res Opin; 2005 Mar; 21(3):381-9. PubMed ID: 15811207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolmitriptan for acute migraine attacks in adults.
    Bird S; Derry S; Moore RA
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD008616. PubMed ID: 24848613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
    Gawel M; Aschoff J; May A; Charlesworth BR;
    Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study].
    Stöckli HR; Sword A
    Praxis (Bern 1994); 2003 Feb; 92(9):379-89. PubMed ID: 12674591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine.
    Dowson AJ; MacGregor EA; Purdy RA; Becker WJ; Green J; Levy SL
    Cephalalgia; 2002 Mar; 22(2):101-6. PubMed ID: 11972576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
    Tepper SJ; Dodick DW; Schmidt PC; Kellerman DJ
    Headache; 2019 Apr; 59(4):509-517. PubMed ID: 30698272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Part II: clinical efficacy and tolerability of zolmitriptan orally disintegrating tablet in the acute treatment of migraine.
    Loder EW; Dowson AJ; Spierings EL
    Curr Med Res Opin; 2005; 21 Suppl 3():S8-12. PubMed ID: 16083518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the efficacy of eletriptan for migraine in women during menstrual and non-menstrual time periods: a pooled analysis of randomized controlled trials.
    Bhambri R; Martin VT; Abdulsattar Y; Silberstein S; Almas M; Chatterjee A; Ramos E
    Headache; 2014 Feb; 54(2):343-54. PubMed ID: 24256184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study. The International 311C90 Long-term Study Group.
    Headache; 1998 Mar; 38(3):173-83. PubMed ID: 9563207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zolmitriptan: a review of its use in migraine.
    Spencer CM; Gunasekara NS; Hills C
    Drugs; 1999 Aug; 58(2):347-74. PubMed ID: 10473025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group.
    Rapoport AM; Ramadan NM; Adelman JU; Mathew NT; Elkind AH; Kudrow DB; Earl NL
    Neurology; 1997 Nov; 49(5):1210-8. PubMed ID: 9371896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.